- Concept UI
- M0229697
- Registry Numbers
- NA8320J834
- Scope Note
- Cyclic peptide that acts as a platelet glycoprotein IIB-IIIA antagonist, reversibly inhibiting the binding of FIBRINOGEN; VON WILLEBRAND FACTOR; and other adhesive molecules to the GPIIB-IIIA RECEPTORS of platelets. It is used in the management of UNSTABLE ANGINA and in patients undergoing coronary ANGIOPLASTY and stenting procedures.
- Terms
-
Eptifibatide
Preferred Term
Term UI
T000940082
Date02/06/2018
LexicalTag
NON
ThesaurusID
-
Epifibratide
Term UI
T000940084
Date02/06/2018
LexicalTag
NON
ThesaurusID
NLM (2005)
-
7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)-
Term UI
T000954951
Date04/08/2019
LexicalTag
NON
ThesaurusID
NLM (2020)
-
Epifibatide
Term UI
T000940083
Date02/06/2018
LexicalTag
NON
ThesaurusID
NLM (2005)